$ACT

Enact Holdings, Inc. (ACT) Secures ~35% Quota Share Reinsurance for 2028 NIW

Enact Holdings (ACT) secured a reinsurance deal to cede 35% of new insurance written in 2028. The agreement, with A-rated reinsurers, aims to manage risk and stabilize capital. Financial details and impacts on returns were not disclosed.

Original reporting
Published Oct 1, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 1, 2026, 8:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Enact Holdings, Inc. (ACT) Secures ~35% Quota Share Reinsurance for 2028 NIW — source image
Decision brief

The 30-second read

$ACTNeutralLow
01

Why it matters

The forward quota share agreement aims to smooth capital requirements for 2028, potentially enhancing financial metrics.

02

Market read

Provides a modest catalyst for ACT shareholders; limited broader market impact.

03

What to watch

Future profitability depends on the terms of ceding commissions and the performance of the ceded book.

Relevance 5/10Novelty 5/10Timing: post-announcement today

Background

Enact Holdings (ACT) is a specialty insurer focusing on niche markets; it uses reinsurance to manage risk and capital.

Company-level read

Ticker impact

$ACTNeutralMedium confidence
Context

Enact Holdings announced a forward quota share reinsurance agreement to cede ~35% of expected 2028 new insurance written.

Expected impact

potential slight upward pressure as capital relief is priced in

Evidence & confidence

Capital relief from the quota share can enhance financial ratios, but the effect is incremental and depends on execution.

Market effects

May signal broader trend of insurers using quota share to manage capital, modestly affecting reinsurance sector sentiment.

Primarily U.S. insurance market; limited regional effect.

Low global relevance beyond niche insurance investors.

Counterpoint

The deal may not materially improve earnings and could mask underlying underwriting risk.

Key entities

  • Enact Holdings, Inc.

    Issuer of the reinsurance agreement.

Related articles

$ACTMedAI 8/10

Enact (ACT) Q2 2026 Earnings Call Transcript

Enact (ACT) reported Q2 2026 adjusted operating income of $177 million, or $1.26 per diluted share, up from $174 million, or $1.15, in Q2 2025. New insurance written rose 15% to $15 billion. FY2026 capital return guidance was raised to $550 million to $600 million. Management cited $274 billion insurance in force and 161% PMIERs sufficiency.